As of September 09, 2026, Estrella Immunopharma's top three insider holders are Jianwei Li (Co Chief Executive Officer, 1.25Mn shares), Cheng Liu (Ceo, 397.44K shares), Jiandong Xu (Chief Financial Officer, 365.49K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Jianwei Li | Co Chief Executive Officer | 1,253,730 | 0 | 1,253,730 | 62.2% | 17 Mar, 2022 |
| 2 | Cheng Liu | Ceo | 397,437 | 0 | 397,437 | 19.7% | 26 Aug, 2026 |
| 3 | Jiandong Xu | Chief Financial Officer | 365,488 | 0 | 365,488 | 18.1% | 25 Aug, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 25 Aug, 2026 | Cheng Liu | Ceo | Acquired M | 100,000 | $0.82 | $81.50K | 397,437 | Direct |
| 25 Aug, 2026 | Cheng Liu | Ceo | Acquired M | 100,000 | $0.00 | $0 | 900,000 | Direct |
| 18 Aug, 2026 | Jiandong Xu | Chief Financial Officer | Acquired M | 100,000 | $0.82 | $81.50K | 365,488 | Direct |
| 18 Aug, 2026 | Jiandong Xu | Chief Financial Officer | Disposed M | 100,000 | — | — | 390,796 | Direct |
| 29 Sep, 2023 | Creek Asset Management, L.P. Owl | TenPercentOwner | Disposed J | 255,000 | $10.86 | $2.77Mn | 0 | Indirect |
| 29 Sep, 2023 | Creek Asset Management, L.P. Owl | TenPercentOwner | Disposed J | 255,000 | $10.86 | $2.77Mn | 0 | Indirect |
| 29 Sep, 2023 | Creek Asset Management, L.P. Owl | TenPercentOwner | Disposed J | 255,000 | $10.86 | $2.77Mn | 0 | Indirect |
| 04 Mar, 2022 | Jianwei Li | Co Chief Executive Officer | Acquired P | 141,970 | $314,700.00 | $44.68Bn | 1,253,730 | Direct |